Although evidence has established that NF-κB is constitutively activated in HCC [50], we did not observe significant alteration of AGK in the HCC cells transfected with IκBα-mut or treated with NF-κB inhibitor II. Here, NFKBIA is linked to hepatocellular carcinoma.